SURGY Stock Overview
Engages in the real estate and tourism business in Turkey. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi Anonim Sirketi Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₺37.64 |
| 52 Week High | ₺84.45 |
| 52 Week Low | ₺28.84 |
| Beta | 0 |
| 11 Month Change | -48.54% |
| 3 Month Change | -35.66% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -30.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| SURGY | TR Hotel and Resort REITs | TR Market | |
|---|---|---|---|
| 7D | -35.4% | -14.0% | -1.7% |
| 1Y | n/a | -6.2% | 6.4% |
Return vs Industry: Insufficient data to determine how SURGY performed against the TR Hotel and Resort REITs industry.
Return vs Market: Insufficient data to determine how SURGY performed against the TR Market.
Price Volatility
| SURGY volatility | |
|---|---|
| SURGY Average Weekly Movement | 10.2% |
| Hotel and Resort REITs Industry Average Movement | 6.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in TR Market | 8.9% |
| 10% least volatile stocks in TR Market | 4.6% |
Stable Share Price: SURGY's share price has been volatile over the past 3 months compared to the TR market.
Volatility Over Time: SURGY's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of TR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2022 | n/a | Omer Elmas | www.surtatilevlerigyo.com.tr |
Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi Anonim Sirketi engages in the real estate and tourism business in Turkey. It develops holiday homes. The company was founded in 2022 and is based in Istanbul, Turkey.
Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi Anonim Sirketi Fundamentals Summary
| SURGY fundamental statistics | |
|---|---|
| Market cap | ₺6.63b |
| Earnings (TTM) | ₺204.56m |
| Revenue (TTM) | n/a |
30.8x
P/E Ratio0.0x
P/S RatioIs SURGY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SURGY income statement (TTM) | |
|---|---|
| Revenue | ₺0 |
| Cost of Revenue | ₺0 |
| Gross Profit | ₺0 |
| Other Expenses | -₺204.56m |
| Earnings | ₺204.56m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.22 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did SURGY perform over the long term?
See historical performance and comparison